openPR Logo
Press release

Polycystic Ovary Syndrome Drugs Market 2024 | Novartis AG, Sanofi, Addex Therapeutics Ltd., Teva Pharmaceutical Industries Limited, Merck KGaA, BIOCAD, Bristol Myers Squibb Co.

01-23-2019 05:52 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Report Insights

Polycystic Ovary Syndrome Drugs Market 2024 | Novartis AG,

Polycystic ovary disorder (PCOS) is a usual hormonal endocrine issue that influences women of baby bearing age that is 15 to 49 years. This ailment otherwise called as Stein-Leventhal Syndrome is described by the structure of cysts on the ovaries prompting an inadequacy of the ovulation setting off hormone in the female body. PCOS, for the most part, happens because of a mix of genetic and environmental variables that cause an abnormal role of the hormones there in the pituitary organ which manages ovulation. A couple of the symptoms of PCOS incorporate acne, infertility, body hair excess, facial, irregular menstruation and other skin problems. PCOS is moreover connected with diseases, for example, obesity2, diabetes, acute depression, obstructive sleep apnea and heart diseases. At present, there are no particular diagnostic tests accessible for the recognition of PCOS nevertheless medical history analysis, vaginal ultrasound, physical examination, and blood tests are widely suggested by general doctors and gynecologists.

Expansion of the overall market is chiefly fuelled by rising occurrence of the disease along with increasing awareness and adoption amid the patient populace. The worldwide market for polycystic ovary syndrome drugs is likely to record a CAGR of 4.7% over the projection period 2016–2024. The worldwide PCOS Drugs Market will be reaching a value of US$ 1,155 Million through 2024. Conversely, rising side effects related to generics and the need for FDA approved drugs may hinder market expansion all through the assessment period.

Request For Report Sample: https://www.researchreportinsights.com/report/sample/110115019/Polycystic-Ovary-Syndrome-Drugs-Market

The worldwide market for PCOS drugs is categorized on the basis of drug class into insulin-sensitizing agents, oral contraceptives, ornithine decarboxylase inhibitors, anti-depressants, diuretics and aromatase inhibitors. The contraceptive drug class category is estimated to record a 5.4% CAGR during the assessment period. The oral contraceptives are normally the chosen therapy for the treatment since they are easily obtainable as OTC medicines. The insulin-sensitizing agent category is estimated to record a 4.8% CAGR throughout the assessment period. The worldwide market for PCOS drugs is categorized on the basis of the distribution channel into fertility clinics, E-commerce, drug stores/OTC and hospital pharmacies. The hospital pharmacies category will be leading the worldwide market for PCOS drugs in revenue terms and is expected to account for a value of about US$ 576 Million by 2024 end. The drugs stores/OTC category was expected to account for 27% of the worldwide market share in valuation terms towards 2016 end.

Request Report Discount: https://www.researchreportinsights.com/report/discount/110115019/Polycystic-Ovary-Syndrome-Drugs-Market

Geographically, the North American region was considered to remain dominant among other regions and with the highest value share of the worldwide market by 2016 end. The Asia Pacific region is projected to account for the maximum 5.6% CAGR throughout the predicted period.

Some of the major players manufacturing in the worldwide market include Novartis AG, Sanofi, Addex Therapeutics Ltd., Teva Pharmaceutical Industries Limited, Merck KGaA, BIOCAD, Bristol Myers Squibb Co., AstraZeneca plc., Crinetics Pharmaceuticals, Inc and Ferring Pharmaceuticals, Inc.

Report Analysis: https://www.researchreportinsights.com/report/rd/110115019/Polycystic-Ovary-Syndrome-Drugs-Market

About Us:
Research Report Insights (RRI) is a leading market intelligence and consulting firm. We deliver a host of services including custom research reports, syndicated research reports, and consulting services which are personalised in nature. RRI delivers a complete packaged solution to clients; this combines current market intelligence, technology inputs, statistical anecdotes, valuable growth insights, 360-degree view of the competitive framework, and anticipated market trends.

Contact Us:
Research Report Insights (RRI)
42 Joseph Street
Port carling P0B 1J0
Muskoka, Ontario1
Phone - +1-631-721-4201
Website: https://www.researchreportinsights.com/
Email: sales@researchreportinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polycystic Ovary Syndrome Drugs Market 2024 | Novartis AG, Sanofi, Addex Therapeutics Ltd., Teva Pharmaceutical Industries Limited, Merck KGaA, BIOCAD, Bristol Myers Squibb Co. here

News-ID: 1523387 • Views:

More Releases from Research Report Insights

Automotive Brake System Market 5.7% of CAGR throughout 2017-2022 Research Report Insights
Automotive Brake System Market 5.7% of CAGR throughout 2017-2022 Research Report …
The global automotive brake system market is anticipated to witnessing a substantial growth due to fresh prospects of the automotive industry in emerging along with developing economies and increased safety concerns by the government. It was stated in the report that the overall growth of the market is expected to reach a market value of above US$ 25 Billion through 2022, exhibiting a strong 5.7% of CAGR throughout 2017-2022. In modern
Automotive Brake System Market 2022 | Continental AG, Robert Bosch GmbH, Wabco Holdings, Inc., ZF Friedrichshafen AG, Aisin Seiki Co, Ltd., Knorr-Bremse AG, Akebono Brake Industry Co. Ltd
Automotive Brake System Market 2022 | Continental AG, Robert Bosch GmbH, Wabco H …
The global automotive brake system market is anticipated to witnessing a substantial growth due to fresh prospects of the automotive industry in emerging along with developing economies and increased safety concerns by the government. It was stated in the report that the overall growth of the market is expected to reach a market value of above US$ 25 Billion through 2022, exhibiting a strong 5.7% of CAGR throughout 2017-2022. In modern
Tarpaulin Sheets Market These factors, thus, are likely to boost the plastic mar …
A tarpaulin is a big sheet of water-proof material available in various sizes, generally being crafted from plastic like HDPE, LDPE. Tarps can be used to refuge any kind of items. Tarpaulins can efficiently be used to cover goods in the course of shipping and then they also can be used to house goods internal of a truck body so they are not uncovered to the elements. The Tarpaulin Sheets Market
Research Report Insights present kayaks market by 21 percent, or over by $42 mil …
Kayaking is a watersport which involves paddling using a double-bladed oar and a small boat known as a kayak. The boats come in a variety of sizes and types, depending on their intended use, but most kayaks feature an enclosed deck which covers the legs. The boat sits low in the water & usually only accommodates the single paddler, but tandem kayaks hold two people and some boats hold three

All 5 Releases


More Releases for PCOS

Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728 Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.
06-20-2024 | Health & Medicine
Fact.MR
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness. Get Free Sample Research Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10043 PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms